Showing results (21-30 of 111) with videos related to
Sort By:
Pageof 12
Gynecologic Oncology|January 21, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcomaMichael D Toboni, Kaitlyn Dinkins, Sharon Wu, et al.Annals of Diagnostic Pathology|July 20, 2024
Detection of human papillomavirus (HPV) in malignant melanomaAdam Bedeir, Hassan Ghani, Cyrus Oster, et al.Archives of Pathology & Laboratory Medicine|April 9, 2019
Autoimmune Lymphoproliferative Syndrome: An OverviewDaniel R Matson, David T YangBlood Advances|April 1, 2021
Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trialEtan Orgel, Celia Framson, Rubi Buxton, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 16, 2025
Genomic Profiling Uncovers a Broader Spectrum of Dermatofibrosarcoma Protuberans: Implications for Diagnosis and TherapySteven Christopher Smith, Kieran Sweeney, Mark G Evans, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.Molecular Cancer Research : MCR|November 10, 2017
Adipocytes Sequester and Metabolize the Chemotherapeutic DaunorubicinXia Sheng, Jean-Hugues Parmentier, Jonathan Tucci, et al.Gynecologic Oncology|September 8, 2023
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutationMichael D Toboni, Sharon Wu, Alex Farrell, et al.Gynecologic Oncology|April 1, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosisShaina F Bruce, Sharon Wu, Jennifer R Ribeiro, et al.Pageof 12